Total Payments
$1,829
2020 Payments
$140.00
Companies
27
Transactions
112
Medicare Patients
176
Medicare Billing
$23,683
Payment Breakdown by Category
Food & Beverage$1,829 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,829 | 112 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $430.07 | 30 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $204.41 | 12 | $0 (2020) |
| Genentech USA, Inc. | $141.28 | 9 | $0 (2018) |
| Gilead Sciences, Inc. | $140.58 | 8 | $0 (2018) |
| Edwards Lifesciences Corporation | $82.54 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $79.76 | 5 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $64.48 | 4 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $62.96 | 4 | $0 (2020) |
| UCB, Inc. | $58.39 | 3 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $58.38 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $140.00 | 9 | GlaxoSmithKline, LLC. ($40.34) |
| 2019 | $486.72 | 26 | Boehringer Ingelheim Pharmaceuticals, Inc. ($89.38) |
| 2018 | $478.65 | 31 | GlaxoSmithKline, LLC. ($156.19) |
| 2017 | $723.48 | 46 | GlaxoSmithKline, LLC. ($189.76) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 3 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: RESPIRATORY | ||||||
| 07/20/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2018 | Cook Medical LLC | COOK MEDICAL PERCUTANEOUS TRACHEOSTOMY (Device) | Food and Beverage | Cash or cash equivalent | $12.77 | General |
| Category: Critical Care | ||||||
| 05/15/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.25 | General |
| 05/04/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Immunology | ||||||
| 04/24/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Respiratory | ||||||
| 04/03/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Immunology | ||||||
| 03/02/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Immunology | ||||||
| 02/27/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Respiratory | ||||||
| 02/26/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: RESPIRATORY | ||||||
| 02/09/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: RESPIRATORY | ||||||
| 01/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: Respiratory | ||||||
| 12/06/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $15.51 | General |
| 11/28/2017 | Respiratory Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| Category: Airway Clearance Therapy | ||||||
| 11/17/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2017 | GlaxoSmithKline, LLC. | BREO (Drug), INCRUSE, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Immunology | ||||||
| 10/27/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/25/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.35 | General |
| Category: Cardiovascular | ||||||
| 10/23/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 84 | $16,773 | $7,000 |
| 2022 | 2 | 29 | 43 | $7,129 | $2,681 |
| 2021 | 2 | 30 | 48 | $8,505 | $3,414 |
| 2020 | 4 | 66 | 102 | $26,063 | $10,589 |
Total Patients
176
Total Services
277
Medicare Billing
$23,683
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 31 | $5,990 | $2,733 | 45.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 38 | $5,393 | $2,275 | 42.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 15 | $5,390 | $1,992 | 37.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 20 | $3,865 | $1,526 | 39.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 23 | $3,264 | $1,155 | 35.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 33 | $6,377 | $2,670 | 41.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 15 | $2,129 | $743.80 | 34.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 25 | 51 | $9,133 | $3,966 | 43.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 14 | 22 | $10,156 | $3,883 | 38.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $4,821 | $1,887 | 39.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 15 | $1,953 | $853.65 | 43.7% |
About Dr. Stuart Lebas, M.D
Dr. Stuart Lebas, M.D is a Pulmonary Disease healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073518510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Lebas, M.D has received a total of $1,829 in payments from pharmaceutical and medical device companies, with $140.00 received in 2020. These payments were reported across 112 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,829).
As a Medicare-enrolled provider, Lebas has provided services to 176 Medicare beneficiaries, totaling 277 services with total Medicare billing of $23,683. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Baton Rouge, LA
- Active Since 06/20/2005
- Last Updated 02/19/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1073518510
Products in Payments
- BREO (Drug) $176.63
- NUCALA (Biological) $139.03
- Esbriet (Biological) $125.96
- STIOLTO RESPIMAT (Drug) $92.37
- FloTrac Sensor (Device) $82.54
- XARELTO (Drug) $79.76
- TRELEGY ELLIPTA (Drug) $66.88
- OFEV (Drug) $61.50
- Vimpat (Drug) $58.39
- ACTHAR (Biological) $58.38
- STIOLTO (Drug) $50.54
- ZERBAXA (Drug) $50.02
- ANORO (Drug) $47.53
- DUPIXENT (Biological) $46.60
- NUZYRA (Drug) $41.83
- Cresemba (Drug) $41.46
- AVYCAZ (Drug) $37.83
- FASENRA (Drug) $36.16
- ELIQUIS (Drug) $33.06
- ANDEXXA (Drug) $32.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Baton Rouge
Robert Hinkle, Md, MD
Pulmonary Disease — Payments: $32,737
Pulmonary Disease $32,737
Dr. Alexander Mulamula, M.d, M.D
Pulmonary Disease — Payments: $9,086
Pulmonary Disease $9,086
Vincent Valentine, Md, MD
Pulmonary Disease — Payments: $6,427
Pulmonary Disease $6,427
Mostafa Aboubakr, Md, MD
Pulmonary Disease — Payments: $4,838
Pulmonary Disease $4,838
Stephen Brierre, Md, MD
Pulmonary Disease — Payments: $2,385
Pulmonary Disease $2,385
Jonathan Richards, Md, MD
Pulmonary Disease — Payments: $2,365
Pulmonary Disease $2,365